BJ 001 companion diagnostic - BJ Bioscience/MEDx Translational Medicine Research
Alternative Names: BJ-001 companion diagnostic - BJ Bioscience/MEDx Translational Medicine ResearchLatest Information Update: 28 Oct 2022
At a glance
- Originator BJ Bioscience
- Developer BJ Bioscience; MEDx (Suzhou) Translational Medicine
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Oct 2022 No recent reports of development identified for clinical-Phase-Unknown development in Cancer(Diagnosis) in China
- 20 Sep 2019 BJ Bioscience and MEDx Translational Medicine Research agree to co-develop BJ 001 companion diagnostic for Cancer (Diagnosis)
- 20 Sep 2019 Clinical trials in Cancer (Diagnosis) in China (unspecified route)